GPB Capital Holdings LLC founder David Gentile and Jeffry Schneider, who helmed Ascendant Capital, a Texas-based firm that marketed GPB funds, began their trial on Monday in New York. Prosecutors allege that Gentile and Schneider orchestrated a Ponzi-like scheme, raising more than $1.8 billion from thousands of unwitting investors. The charges against them include securities fraud, wire fraud, and conspiracy. Central to the prosecution’s case is the testimony of Jeffrey Lash, a former GPB managing director who had previously pleaded guilty to wire fraud. Lash is expected to provide critical insights into the alleged misuse of funds to cover shortfalls and personal enrichment of Gentile and Schneider.
The alleged scheme not only misrepresented the performance of GPB’s investments but also siphoned off substantial financial resources from the company. According to court documents, the funds, which were supposed to be allocated for legitimate investment purposes, were diverted to pay off earlier investors and cover expenses that were not disclosed to the new investors. These claims have sparked significant interest and concern among legal professionals and investment communities alike.
For extensive details of the trial proceedings and charges, see the official press release from the U.S. Attorney’s Office for the Eastern District of New York. Additional context and ongoing coverage can be accessed via Bloomberg Law.